1. Efficacy and safety of everolimus plus exemestane in postmenopausal women with hormone receptor‐positive, human epidermal growth factor receptor 2‐negative locally advanced or metastatic breast cancer: Results of the single‐arm, phase IIIB 4EVER trial. Issue 4 (30th October 2018) Authors: Tesch, Hans; Stoetzer, Oliver; Decker, Thomas; Kurbacher, Christian M.; Marmé, Frederik; Schneeweiss, Andreas; Mundhenke, Christoph; Distelrath, Andrea; Fasching, Peter A.; Lux, Michael P.; Lüftner, Diana; Hadji, Peyman; Janni, Wolfgang; Muth, Mathias; Kreuzeder, Julia; Quiering, Claudia; Taran, ... Journal: International journal of cancer Issue: Volume 144:Issue 4(2019) Page Start: 877 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗